Category: Infection
Lancet: Where is the next SARS-CoV-2 variant of concern?
“Curing COVID-19 infections in immunocompromised individuals is of crucial importance.”… More...
Spillover of new BA.1 sublineage from persistently infected COVID patient into the community
“The new BA.1 sub-lineage transmitted to five independent cases, including two reported in GISAID from a different surveillance effort”…
Gisaid: BA.1 sublineage with T6001C and S mutations: S:E96D, S:L167T, S:R346T, S:L455W, S:K458M, S:E484V, S:H681R, S:P688V, detected in New York, USA #663. More...
Ninety Monkeypox cases across the UK
The UK Health Security Agency (UKHSA) has detected 8 additional cases of monkeypox in England on 26th May 2022. More...
Monkeypox: Prolonged upper respiratory tract viral DNA shedding
“Notable disease features included viraemia, prolonged monkeypox virus DNA detection in upper respiratory tract swabs, reactive low mood, and one patient had a monkeypox virus PCR-positive deep tissue abscess”
“We reviewed all cases since the inception of the HCID (airborne) network between Aug 15, 2018, and Sept 10, 2021, identifying seven patients. More...
Preprint: Monkeypox genetic divergence and first signs of microevolution
“We have already detected the first signs of microevolution within the outbreak cluster, namely the emergence of 7 SNPs, leading to 3 descendant branches.” More...
Preprint: Association between air pollution and COVID-19 severity
Chronic exposure to air pollution may contribute to severe outcomes after SARS-CoV-2 infection, particularly exposure to O3. More...
Preprint: Monkeypox has epidemic potential
“Monkeypox has epidemic potential”
“We conclude that circulation of smallpox, followed by worldwide smallpox vaccination, have previously protected human populations from monkeypox epidemics. More...
CDC: A quarter of elderly Covid survivors may have ongoing symptoms
CDC: “One in five COVID-19 survivors aged 18–64 years and one in four survivors aged ≥65 years experienced at least one incident condition that might be attributable to previous COVID-19. More...
Moderna looks at producing a Monkeypox vaccine
Moderna is considering turning its mRNA vaccine platform towards finding a vaccine to defend against Monkeypox, according to a recent tweet by the company. More...